Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Whole metagenome sequencing: not deep enough for complete microbial function recovery.

Microbiome·2026
Same author

Mental Health and Survival in Medicare Beneficiaries With Lung and Head and Neck Cancer.

Psycho-oncology·2026
Same author

CD38⁺ endothelial remodeling marks spatially patterned vasculopathy in rapidly advancing periodontitis and peri-implantitis.

Nature communications·2026
Same author

Population-level prevalence and risk of oral HPV infection with or without HPV vaccination.

Human vaccines & immunotherapeutics·2026
Same author

Cumulative Incidence and Risk of Depression After Opioid Use in Head and Neck Cancer Patients.

Head & neck·2026
Same author

Oral microbiome diversity, community- and taxon-level differences by oral human papillomavirus (HPV) and race/ethnicity.

Infectious agents and cancer·2026

相关实验视频

Updated: May 6, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

GARD:基于基因组数据的药物重定位在头癌中,使用大型语言模型验证.

Pradham Tanikella1, William Nenad2, Christophe Courtine3

  • 1Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Cancers
|March 14, 2026
PubMed
概括

通过分析基因组数据和蛋白质网络,GARD管道确定了用于头癌 (HNC) 的新药重定位候选药物. 这种方法有助于发现针对个性化HNC治疗的向疗法.

关键词:
药物重用是为了改变药物的用途.基因组学就是基因组学.头部和部癌症 头部和部癌症

更多相关视频

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.3K

相关实验视频

Last Updated: May 6, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.3K

科学领域:

  • 在瘤学瘤学.
  • 基因组学就是基因组学.
  • 生物信息学是一种生物信息学.

背景情况:

  • 头癌 (HNC) 的治疗改善有限.
  • 药物重新定位为新的HNC疗法提供了一个具有成本效益的策略.
  • 现有的HNC治疗方法显示患者的治疗结果不足于最佳.

研究的目的:

  • 开发GARD管道,用于识别HNC药物重用候选人.
  • 为了利用基因组改变和基于网络的药物发现方法.
  • 为了发现头癌的新治疗方案.

主要方法:

  • 来自TCGA的综合多omics数据 (CNV,SOM),按HPV状态分层.
  • 识别了风险基因,并使用蛋白质-蛋白质相互作用 (PPI) 网络扩展了它们.
  • 使用PubMed文献和LLM验证了基因-HNC关联,然后将基因映射到DrugBank.

主要成果:

  • 在HPV亚组中确定了重要的HNC风险基因 (例如,PIK3CA,SOX2,TP53).
  • 网络扩张揭示了其他可向基因 (例如EGFR,ERBB2,FGFR).
  • 药物测绘确定了临床试验药物和新型重定位候选药物 (例如,阿法替尼,阿穆瓦替尼,阿司匹林).

结论:

  • 该GARD管道为HNC药物重定向提供了一个系统的,基因组学驱动的框架.
  • HPV分层和文献验证提高了确定候选者的准确性和信心.
  • 这种方法通过完善现有疗法和发现新的疗法来促进个性化治疗策略.